At BELLUS, we are focused on advancing novel therapeutics for conditions with high unmet medical need. Read More

At BELLUS, we are focused on advancing novel therapeutics for conditions with high unmet medical need. Read More

Blog

July 19, 2017 Hits and Misses from the Cough Conferences – Part 1: A Review of the Merck P2X3 Antagonist Data
Over the course of the last couple of months, the BELLUS Health team attended two important conferences: the American Thoracic Society (ATS) Conference and the American Cough Conference (ACC). While ATS is a very large and broad respiratory conference, ACC is a highly-specialized conference focused primarily on chronic cough. It was at ATS that Merck presented for the first time the latest...
Read More
May 31, 2017 Understanding Chronic Cough
As part of our chronic cough program’s due diligence process, we interviewed many clinician experts in the field who identified chronic cough as an area with high unmet medical need. Not only does chronic cough affect a large proportion of the population - about 10% of adults in most industrialized countries - but there is a large percentage of highly underserved patients (10-40% 1,2 ) that...
Read More

Share this

Sign up for email alerts

Email Address *
 
Enter the code shown above.